Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Noah L. Rosenberg currently holds 2,357 shares of Travere Therapeutics, Inc. (TVTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Noah L. Rosenberg has been a net seller of TVTX stock. They have purchased $10.0K and sold $366.8K worth of shares.
Noah L. Rosenberg's most recent insider trade was on Nov 25, 2025, when they purchased 2,357 shares at $4.24 per share.
Noah L. Rosenberg serves as Executive at Travere Therapeutics, Inc. (TVTX). They have executed 27 insider transactions totaling $376.8K over their tenure at the company.
Noah L. Rosenberg holds the position of Executive at Travere Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 8 years and currently hold a stake valued at $0.
Noah L. Rosenberg has shown a selling trading pattern, with $10.0K in total purchases and $366.8K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Noah L. Rosenberg was on Feb 2, 2021, when they sold $38.4K worth of TVTX shares. This transaction involved 1,250 shares at $30.75 per share.
Noah L. Rosenberg currently owns 2,357 shares of Travere Therapeutics, Inc. (TVTX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Noah L. Rosenberg's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Noah L. Rosenberg has 27 Form 4 filings on record as an insider at Travere Therapeutics, Inc..
Set alerts for Noah L. Rosenberg and 40,000+ other insiders.